These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1027632)

  • 1. An in vitro method for screening compounds for the effect on the rate of sickling of erythrocytes.
    Mackenzie RD; Gleason EM; Schatzman GL; Cawein MJ
    J Int Med Res; 1976; 4(6):375-81. PubMed ID: 1027632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisickling effects of membrane-interacting compounds.
    Ohnishi ST
    Blood Cells; 1982; 8(2):337-43. PubMed ID: 6130805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of the rate of erythrocyte sickling by RMI 11,071A and its possible mechanism.
    MacKenzie RD; Gleason EM; Schatzman GL; Cawein MJ
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):224-6. PubMed ID: 504233
    [No Abstract]   [Full Text] [Related]  

  • 5. Bepridil as an antisickling agent: membrane internalization and cell rigidity.
    Johnson RM; Acquaye C; Féo C; Sarnaik S
    Am J Hematol; 1994 Aug; 46(4):310-8. PubMed ID: 8037182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability.
    Berkowitz LR; Orringer EP
    J Clin Invest; 1981 Nov; 68(5):1215-20. PubMed ID: 7298848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
    Roth E; Elbaum D; Godoy E; Nagel RL
    Nouv Rev Fr Hematol (1978); 1978; 20(4):611-9. PubMed ID: 752153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of erythrocyte sickling by thiol reagents.
    Garel MC; Domenget C; Galacteros F; Martin-Caburi J; Beuzard Y
    Mol Pharmacol; 1984 Nov; 26(3):559-65. PubMed ID: 6493211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane expansion as a mechanism explaining the antisickling action of ticlopidine observed in vitro.
    Sablayrolles M; Wajcman H; Castaigne JP; Labie D
    Am J Hematol; 1985 Feb; 18(2):121-30. PubMed ID: 3970009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic and rheologic effects of the antisickling agent ethacrynic acid and its N-butylated derivative on normal and sickle erythrocytes.
    Orringer EP; Blythe DS; Whitney JA; Brockenbrough S; Abraham DJ
    Am J Hematol; 1992 Jan; 39(1):39-44. PubMed ID: 1536139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisickling activity of amino acid benzyl esters.
    Gorecki M; Acquaye CT; Wilchek M; Votano JR; Rich A
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):181-5. PubMed ID: 6928612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of erythrocyte calcium transport by cetiedil.
    Levine SN; Berkowitz LR; Orringer EP
    Pharmacology; 1988; 36(1):44-51. PubMed ID: 2829242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
    Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
    J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of anthocyanin extracts from Justicia secunda Vahl on the solubility of haemoglobin S and membrane stability of sickle erythrocytes.
    Mpiana PT; Ngbolua KN; Bokota MT; Kasonga TK; Atibu EK; Tshibangu DS; Mudogo V
    Blood Transfus; 2010 Oct; 8(4):248-54. PubMed ID: 20967165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antisickling role of uric acid in sickle cell disease.
    Ekeke GI; Nduka N
    Trop Geogr Med; 1987 Apr; 39(2):152-6. PubMed ID: 3629708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickling-suppressive effects of chrysin may be associated with sequestration of deoxy-haemoglobin, 2,3-bisphosphoglycerate mutase, alteration of redox homeostasis and functional chemistry of sickle erythrocytes.
    Muhammad A; Waziri AD; Forcados GE; Sanusi B; Sani H; Malami I; Abubakar IB; Muhammad A; Muhammad RA; Mohammed HA
    Hum Exp Toxicol; 2020 Apr; 39(4):537-546. PubMed ID: 31876182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of transport and possible mechanism of action of L-phenylalanine benzyl ester as an anti-sickling agent.
    Acquaye CT; Young JD; Ellory JC; Gorecki M; Wilchek M
    Biochim Biophys Acta; 1982 Dec; 693(2):407-16. PubMed ID: 7159585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive in vitro effects of anti-sickling drugs.
    Stuart J; Mojiminiyi FB; Stone PC; Culliford SJ; Ellory JC
    Br J Haematol; 1994 Apr; 86(4):820-3. PubMed ID: 7918079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of erythrocyte membrane ATPases with antisickling and anaesthetic substances and ionophoric antibiotics.
    Abu-Salah KM
    Life Sci; 1996; 58(3):187-93. PubMed ID: 9499159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viscosity and filtrability measurements of sickle-cell suspensions in the development of anti-sickling drugs.
    Ohnishi ST
    Blood Cells; 1982; 8(1):79-87. PubMed ID: 7115980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.